Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation in Children with Beta-Thalassemia Major

被引：0
|
作者：
Yesilipek, M. Akif [1 ]
Karasu, Gulsun [2 ]
Kaya, Zuhre [3 ]
Kuskonmaz, Baris B. [4 ]
Uygun, Vedat [1 ]
Dag, Ilkiz [5 ]
Birkent, Asli [5 ]
Ertem, Mehmet [6 ]
机构：
[1] Bahcesehir Univ, Dept Pediat Hematol, Fac Med, Antalya, Turkey
[2] Bahcesehir Univ, Dept Pediat Hematol, Fac Med, Istanbul, Turkey
[3] Gazi Univ, Dept Pediat Hematol, Fac Med, Ankara, Turkey
[4] Hacettepe Univ, Fac Med, Dept Pediat Hematol, TR-06100 Ankara, Turkey
[5] Gida & Tarim Urunleri San & Tic AS, Novartis Oncol, Novartis Saglik, Istanbul, Turkey
[6] Ankara Univ, Fac Med, Dept Pediat Hematol, TR-06100 Ankara, Turkey
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation
    Vallejo, Carlos
    Batlle, Montserrat
    Vazquez, Lourdes
    Solano, Carlos
    Sampol, Antonia
    Duarte, Rafael
    Hernandez, Dolores
    Lopez, Javier
    Rovira, Montserrat
    Jimenez, Santiago
    Valcarcel, David
    Belloch, Vicente
    Jimenez, Monica
    Jarque, Isidro
    HAEMATOLOGICA, 2014, 99 (10) : 1632 - 1637
  • [22] A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)
    Zhang, Fengkui
    Peng, Guangxin
    He, Guangsheng
    Chang, Hong
    Gao, Sujun
    Liu, Xinjian
    Chen, Tong
    Li, Pei
    Han, Bing
    Miao, Miao
    Ge, Zheng
    Ge, Xiaoyan
    Li, Fei
    Li, Yingmei
    Wang, Shunqing
    Wang, Yi
    Shen, Yaqi
    Tai, Yanfei
    Zhang, Tao
    Zhu, Bo
    Zou, Jianjun
    BLOOD, 2020, 136
  • [23] Immune recovery after in vivo T-cell depletion myeloablative conditioning hematopoietic stem cell transplantation in severe beta-thalassemia children
    Qin, Fang
    Shi, Lingling
    Li, Qiaochuan
    Zhang, Zhongming
    Liu, Lianjin
    Li, Jing
    Yang, Gaohui
    Lai, Yong-Rong
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (04) : 342 - 350
  • [24] A Prospective, Multicenter, Single-arm, Observational Study to Evaluate the Safety and Effectiveness of Vedolizumab in Real-world Clinical Practice in China: Interim Analysis of Safety results
    Zheng, C.
    Chen, B.
    Yu, J.
    Wang, X.
    Li, L.
    Hu, Y.
    Xie, L.
    Liu, M.
    Chen, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1437 - I1439
  • [25] Effects of deferoxamine versus deferasirox on hematology and liver parameters in children with beta-thalassemia major: A cross-sectional study from a single center
    Al-Nimer, Marwan S.
    Hamasalih, Raz M.
    Ratha, Rawa
    IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2023, 13 (04) : 251 - 259
  • [26] Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
    Lin, Chien-Ting
    Hsueh, Po-Ren
    Wu, Shang-Ju
    Yao, Ming
    Ko, Bor-Sheng
    Li, Chi-Cheng
    Hsu, Cheng-An
    Tang, Jih-Luh
    Tien, Hwei-Fang
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (11) : 2310 - 2315
  • [27] Safety but Limited Efficacy of Ensartinib in ROS1-Positive NSCLC: A Single-Arm, Multicenter Phase 2 Study
    Ai, Xinghao
    Wang, Qiming
    Cheng, Ying
    Liu, Xiaoqing
    Cao, Lejie
    Chen, Jianhua
    Dong, Xiaorong
    Zhou, Jianying
    Fan, Yun
    Huang, Cheng
    Cui, Jiuwei
    Wang, Yan
    Chen, Gongyan
    Ding, Cuimin
    Gao, Beili
    Li, Xingya
    Wang, Ziping
    Zhang, Helong
    Ding, Lieming
    Wang, Yang
    Yuan, Xiaobin
    Cheng, Hongke
    Wang, Tao
    Lu, Shun
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (11) : 1959 - 1963
  • [28] A Phase 1/2 Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma in the First Salvage Setting: Interim Results
    LaCasce, Ann
    Sawas, Ahmed
    Bociek, R. Gregory
    Ansell, Stephen
    Vose, Julie
    O'Meara, Megan
    Advani, Ranjana
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S161 - S161
  • [29] INTERIM RESULTS FROM A PHASE 2A, OPEN-LABEL, DOSE-FINDING STUDY TO DETERMINE THE SAFETY, EFFICACY, AND TOLERABILITY OF SOTATERCEPT (ACE-011) IN ADULTS WITH BETA-THALASSEMIA
    Porter, J.
    Cappellini, M. D.
    Origa, R.
    Forni, G. L.
    Laadem, A.
    Galacteros, F.
    Voskaridou, E.
    Miteva, D.
    Sung, V.
    Chopra, R.
    Arlet, J. B.
    Ribeil, J. A.
    Klesczewski, K.
    Attie, K.
    Garbowski, M.
    Graziadei, G.
    Balocco, M.
    Hermine, O.
    HAEMATOLOGICA, 2014, 99 : 230 - 230
  • [30] A multicenter, open-label, single-arm phase 1/2 study to evaluate the safety and efficacy of FCN-159 in pediatric participants with neurofibromatosis type 1
    Hu, Xiaojie
    Wang, Jinhu
    Li, Wenbin
    Zeng, Kang
    Li, Yanling
    Tao, Juan
    Guan, Zhonghai
    Kang, Zhuang
    Xu, Zhongyuan
    Li, Changxing
    Ma, Yaohui
    Yang, Liu
    Wu, Zhuli
    Han, Pu
    Lin, Hongmei
    Li, Ben
    Hui, Ai-Min
    Wang, Xingli
    Lin, Xiaoxi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345